The research also highlights potential avenues for repurposing existing drugs. Researchers found that trimethoprim and ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Antimicrobial resistance could claim 39 million lives by 2050, yet the pipeline for new antibiotics is drying up. U.S. policy ...
Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...
Treatment MarketThe global urinary tract infection (UTI) treatment market is poised for consistent growth, with an estimated ...
Companion Animal Specialty Drugs MarketThe global companion animal drugs market, valued at USD 36.7 billion in 2022, is ...
Researchers are re-examining streptothricin, an antibiotic that was first created more than 80 years ago, in hopes of determining whether it might effectively combat drug-resistant superbugs.
In 2019, bacterial antibiotic resistance killed an estimated 4.95 million people worldwide. By targeting the specific genes responsible for resistance to existing drugs, our approach could lead to ...
Within the last five years, doctors from Intermountain Health have become nationally known for their research into antibiotic use. This fall, the medical system was awarded two national grants to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback